Session 3: Malignant Transformation in WM
The following abstracts represent the presentations given at IWWM-9 (Amsterdam-2016), Session 3: Malignant Transformation in WM:
Session Chair: Linda Pilarski (Canada)
What phenotypic and genomic changes define transformation from IgM MGUS to symptomatic WM? B. Paiva (Spain)
Does the mutational landscape change with evolution of IgM MGUS to active WM? C. Jimenez (Spain)
Does transcriptome-wide analysis demonstrate significant differences in gene expression variability between WM and IgM MGUSBM B cell clones? A. Trojani (Italy)
Clonal complexity in Waldenstrom macroglobulinemia and potential therapeutic options L. Pilarski (Canada)